Literature DB >> 25809802

Skeletal muscle ceramide species in men with abdominal obesity.

M P de la Maza1, J M Rodriguez, S Hirsch, L Leiva, G Barrera, D Bunout.   

Abstract

BACKGROUND: Obesity is a risk factor for diabetes and its consequences, including accelerated ageing and mortality. The underlying factor could be accumulation of certain lipid moieties, such as ceramides (CER) and diacylgycerol (DAG) within muscle tissue, which are known to promote insulin resistance (IR), induce inflammation and oxidative injury, ultimately altering muscle function. AIM: First, to study the relationship between body composition and age (independent variables) with skeletal muscle accumulation of lipid species, oxidative injury and strength. Second, to analyze the relationship between muscle tissue metabolites and insulin resistance, inflammation and lymphocyte telomere length, the latter as an indicator of ageing.
METHODOLOGY: The sample included 56 healthy sedentary males, scheduled for inguinal hernia surgery, aged 27 to 80 y. Each individual was subject to anthropometric measurements, body composition assessment through radiologic densitometry (DEXA), measurement of handgrip and quadriceps strength, serum biochemical parameters (lipoproteins, creatinine, high sensitivity C reactive protein [hsCRP], fasting and post glucose insulin and glucose concentrations for calculation of IR through the Matsuda and HOMA-IR indexes), and extraction of peripheral leukocytes for measurement of telomere length. During the surgical procedure, a sample of muscle tissue was obtained (anterior abdominal oblique) in order to measure CER and DAG (and sub species according to chain length and saturation) by mass spectrometry, 4 hydroxy-2-nonenal adducts (4-HNE) using electron microscopy immunohistochemistry, and carboxymethyl-lisine (CML) by immunohistochemistry, the latter as indicators of oxidative stress (OS).
RESULTS: Body mass index (BMI) of twenty six individuals was > 25 k/m2, while BMI of 7 was > 30 k/m2. Overweight/obese individuals, did not exhibit differences in skeletal muscle lipid metabolites, however total CER and specific long chain CER sub-species (20 and 22 carbon) increased significantly among individuals with a central fat distribution (n = 14) as well as in glucose intolerant subjects (n =23). A negative association was found between mononuclear leukocyte telomere length and 20 and 22 carbon CER (rho = - 0.4 and -0.5 0 p < 0.05). Muscle strength was not associated with any of the measured muscle metabolites or markers of OS. A multiple regression analysis accepted central abdominal fat and telomere length as significant predictors of CER (R2 = 0.28).
CONCLUSIONS: An association was found between accumulation of specific ceramide species in muscle tissue and abdominal obesity, glucose intolerance and shortening of leukocyte telomeres, although not with muscle oxidative injury or dysfunction.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25809802     DOI: 10.1007/s12603-014-0548-7

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  48 in total

Review 1.  Re-evaluating lipotoxic triggers in skeletal muscle: relating intramyocellular lipid metabolism to insulin sensitivity.

Authors:  Madeleen Bosma; Sander Kersten; Matthijs K C Hesselink; Patrick Schrauwen
Journal:  Prog Lipid Res       Date:  2011-11-19       Impact factor: 16.195

2.  Telomere length in blood and skeletal muscle in relation to measures of glycaemia and insulinaemia.

Authors:  S Ahmad; A Heraclides; Q Sun; T Elgzyri; T Rönn; C Ling; B Isomaa; K-F Eriksson; L Groop; P W Franks; O Hansson
Journal:  Diabet Med       Date:  2012-10       Impact factor: 4.359

3.  Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes.

Authors:  Michael Gaster; Arild C Rustan; Henning Beck-Nielsen
Journal:  Diabetes       Date:  2005-03       Impact factor: 9.461

4.  Identification of individuals with insulin resistance using routine clinical measurements.

Authors:  Steven E Stern; Ken Williams; Eleuterio Ferrannini; Ralph A DeFronzo; Clifton Bogardus; Michael P Stern
Journal:  Diabetes       Date:  2005-02       Impact factor: 9.461

5.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

6.  Ethnic differences in hepatic steatosis: an insulin resistance paradox?

Authors:  Richard Guerrero; Gloria L Vega; Scott M Grundy; Jeffrey D Browning
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

7.  The role of skeletal muscle sphingolipids in the development of insulin resistance.

Authors:  Marek Straczkowski; Irina Kowalska
Journal:  Rev Diabet Stud       Date:  2008-05-10

8.  Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited.

Authors:  John J Dubé; Francesca Amati; Maja Stefanovic-Racic; Frederico G S Toledo; Sarah E Sauers; Bret H Goodpaster
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-03-04       Impact factor: 4.310

9.  Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption.

Authors:  John R Ussher; Timothy R Koves; Virgilio J J Cadete; Liyan Zhang; Jagdip S Jaswal; Suzanne J Swyrd; David G Lopaschuk; Spencer D Proctor; Wendy Keung; Deborah M Muoio; Gary D Lopaschuk
Journal:  Diabetes       Date:  2010-06-03       Impact factor: 9.461

10.  Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes.

Authors:  M Straczkowski; I Kowalska; M Baranowski; A Nikolajuk; E Otziomek; P Zabielski; A Adamska; A Blachnio; J Gorski; M Gorska
Journal:  Diabetologia       Date:  2007-08-28       Impact factor: 10.122

View more
  14 in total

1.  Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes.

Authors:  Nicholas T Broskey; Diana N Obanda; Jeffrey H Burton; William T Cefalu; Eric Ravussin
Journal:  Metabolism       Date:  2018-01-04       Impact factor: 8.694

2.  CrossTalk proposal: Intramyocellular ceramide accumulation does modulate insulin resistance.

Authors:  Scott A Summers; Bret H Goodpaster
Journal:  J Physiol       Date:  2016-03-20       Impact factor: 5.182

Review 3.  Lipid deposition and metaflammation in diabetic kidney disease.

Authors:  Alla Mitrofanova; Antonio M Fontanella; Sandra Merscher; Alessia Fornoni
Journal:  Curr Opin Pharmacol       Date:  2020-11-01       Impact factor: 5.547

4.  Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study.

Authors:  Ian J Neeland; Shruti Singh; Darren K McGuire; Gloria L Vega; Thomas Roddy; Dermot F Reilly; Jose Castro-Perez; Julia Kozlitina; Philipp E Scherer
Journal:  Diabetologia       Date:  2018-08-29       Impact factor: 10.122

Review 5.  Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.

Authors:  Peter J Meikle; Scott A Summers
Journal:  Nat Rev Endocrinol       Date:  2016-10-21       Impact factor: 43.330

Review 6.  Contribution of specific ceramides to obesity-associated metabolic diseases.

Authors:  Philipp Hammerschmidt; Jens C Brüning
Journal:  Cell Mol Life Sci       Date:  2022-07-05       Impact factor: 9.207

7.  Sphingolipid changes do not underlie fatty acid-evoked GLUT4 insulin resistance nor inflammation signals in muscle cells.

Authors:  Nicolas J Pillon; Scott Frendo-Cumbo; Maya R Jacobson; Zhi Liu; Paul L Milligan; Hai Hoang Bui; Juleen R Zierath; Philip J Bilan; Joseph T Brozinick; Amira Klip
Journal:  J Lipid Res       Date:  2018-05-23       Impact factor: 5.922

Review 8.  Lipid-Induced Insulin Resistance in Skeletal Muscle: The Chase for the Culprit Goes from Total Intramuscular Fat to Lipid Intermediates, and Finally to Species of Lipid Intermediates.

Authors:  Soressa M Kitessa; Mahinda Y Abeywardena
Journal:  Nutrients       Date:  2016-07-29       Impact factor: 5.717

9.  Serum Metabolomics of Activity Energy Expenditure and its Relation to Metabolic Syndrome and Obesity.

Authors:  Marie S A Palmnäs; Karen A Kopciuk; Rustem A Shaykhutdinov; Paula J Robson; Diane Mignault; Rémi Rabasa-Lhoret; Hans J Vogel; Ilona Csizmadi
Journal:  Sci Rep       Date:  2018-02-19       Impact factor: 4.379

10.  Beyond fitness tracking: The use of consumer-grade wearable data from normal volunteers in cardiovascular and lipidomics research.

Authors:  Weng Khong Lim; Sonia Davila; Jing Xian Teo; Chengxi Yang; Chee Jian Pua; Christopher Blöcker; Jing Quan Lim; Jianhong Ching; Jonathan Jiunn Liang Yap; Swee Yaw Tan; Anders Sahlén; Calvin Woon-Loong Chin; Bin Tean Teh; Steven G Rozen; Stuart Alexander Cook; Khung Keong Yeo; Patrick Tan
Journal:  PLoS Biol       Date:  2018-02-27       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.